NEW YORK--(BUSINESS WIRE)--Synchron, the brain-computer interface (BCI) company developing endovascular technology to restore functionality in individuals with motor impairment, today announced the ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Synchron has raised $200 million to support ...

Synchron’s brain computer interface (BCI) device caused no deaths or permanent increases in disability in the first year of a U.S. clinical trial, the company said Monday. The study enrolled six ...

In recent years, clinical trials have been conducted to implant implants in the brains of physically disabled people to enable them to operate software and games, and Neuralink, founded by Elon Musk, ...

Apple has partnered with Synchron, a brain-computer interface (BCI) company, to create a brain implant that will allow users to control their iPhone, iPad, or Apple Vision Pro without gesture or voice ...

Mark Jackson, who lives with ALS, received Synchron's Stentrode system brain-computer interface (BCI) implant in August 2023. In the video, Jackson says that he wants to use whatever time he has left ...

US company Synchron has developed a minimally invasive brain interface for digital devices. In cooperation with Apple, it now controls devices such as tablets. The special feature of Synchron's ...

Medical device leaders who have built and scaled category-defining products join Synchron to help drive its next-generation brain-computer interface platform as well as accelerate towards ...

BackgroundAlzheimer's disease (AD) is the most common neurodegenerative disorder, characterized by progressive cognitive decline and memory impairment ...

Momentum behind brain-computer interfaces is growing, but experts say that design innovations are needed to help them survive decades in.